Unlike PCR, the regions are amplified in E. coli, not in vitro, and thus are subject to review by the E. coli replication machinery. Both of these advances present new options for DNA engineering.

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks all but defunct after the two partners halted a phase 3 trial.

One person has died in Colorado. McDonald’s E. coli outbreak and other incidents raise concerns about U.S. food safety A deadly E. coli outbreak linked to a popular McDonald’s menu item is the ...